Study
Insuline Glargine and Lantus(R) Trial 2 - Daytona Beach, Florida - #CCRI11628
Summary
To test the effectivness, safety, and tolerability of a new formulation of Insulin Glargine and Lantus(R) for Type 2 Diabetes
Qualifications - Inclusions & Exclusions
Inclusion
Type 2 Diabetes
Age 18 or Older

Exclusions:
Hemoglobin A1c between 7 and 10 at screening
Diabetes other than Type 2
Use of Insulin pump in the last 6 months before screening visit
History of drug or alcohol abuse within 6 months prior to screening

Compensation for Time and Travel
Participants who qualify will receive reimbursement for their time and participation for an amount up to $640
Location
Daytona Beach, Volusia County
Daytona Beach, Florida 32117
In/Outpatient
Outpatient
Learn More
* Required Fields
Email:
*
First Name: *
Last Name: *
Daytime Phone:
Evening Phone:
Source:
If Other:
Comments: